A2A Pharmaceuticals, Inc. - 16 Aug 2022 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Issuer symbol
BMEA
Transactions as of
16 Aug 2022
Net transactions value
-$425,648
Form type
4
Filing time
19 Aug 2022, 06:56:16 UTC
Previous filing
25 Jul 2022
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Purchase $425,648 -30,684 -0.71% $13.87 4,300,000 16 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in multiple transaction in a range of prices from 13.65 to 14.01 and an average price of 13.872. Details of the specific trades are available upon request